HEDIS® Results

Medicaid HEDIS® Annual Rates.

Molina’s scores for the past two years are below. You can see how Molina performs compared to our target goal.

Measure

2023 Rate

2023 Goal

2024 Rate

2024 Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

31.34%

64.90%

41.67%

66.15%

Annual Dental Visits (ADV) Total

45.66%

54.60%

 

 

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

48.06%

46.74%

37.46%

48.16%

Appropriate Testing for Pharyngitis (CWP)

62.64%

77.56%

74.04%

85.11%

Appropriate Treatment for Upper Respiratory Infection (URI) Total

90.36%

93.08%

88.02%

91.27%

Asthma Medication Ratio (AMR) Total

57.69%

69.41%

67.34%

70.56%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

62.96%

66.19%

64.80%

67.03%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

52.80%

68.61%

56.45%

71.78%

Breast Cancer Screening (BCS)

47.30%

55.25%

 

 

Breast Cancer Screening (BCS-E)

47.23%

54.94%

49.36%

56.66%

Cervical Cancer Screening (CCS)

37.71%

59.85%

43.55%

60.10%

Childhood Immunization Status (CIS) Combination #10

25.33%

35.04%

18.25%

31.32%

Chlamydia Screening in Women (CHL) Total

58.06%

61.07%

57.51%

61.46%

Controlling High Blood Pressure (CBP)

39.66%

65.45%

57.66%

67.40%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

75.30%

80.86%

76.74%

83.51%

Eye Exam for Patients With Diabetes (EED)

36.74%

56.20%

40.63%

57.09%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

30.77%

27.73%

30.29%

27.62%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

46.25%

46.35%

42.00%

44.33%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

34.32%

41.03%

46.28%

42.86%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

42.14%

37.31%

39.81%

37.64%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

NA

57.90%

65.17%

56.86%

Follow-Up for Children Prescribed ADHD Medication (ADD-E) Continuation and Maintenance Phase

 

 

68.97%

56.83%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

44.28%

55.72%

46.23%

59.64%

Immunizations for Adolescents (IMA) Combination #2

31.39%

38.93%

27.74%

38.69%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

21.79%

16.94%

24.06%

16.78%

Kidney Health Evaluation for Patients with Diabetes (KED)

38.74%

38.80%

45.11%

42.10%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

40.91%

39.01%

41.41%

41.92%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) Blood Glucose and Cholesterol Testing Total

 

 

41.41%

41.41%

Pharmacotherapy for Opioid Use Disorder (POD) Total

16.40%

31.93%

7.78%

29.01%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

60.98%

75.79%

64.81%

74.78%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

73.17%

86.96%

79.63%

86.54%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

125.28%

≤ 92.72%

115.62%

≤ 91.24%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

83.70%

86.86%

85.40%

86.89%

Prenatal and Postpartum Care (PPC) Postpartum Care

64.23%

80.78%

66.42%

82.48%

Prenatal Immunization Status (PRS) Combination Rate

12.22%

25.81%

 

 

Prenatal Immunization Status (PRS-E) Combination Rate

12.22%

25.81%

12.77%

24.92%

Risk of Continued Opioid Use (COU) 31-Day Total

3.62%

≤ 2.45%

2.91%

≤ 2.79%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

76.42%

81.64%

81.37%

83.00%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

64.81%

73.63%

64.89%

74.07%

Statin Therapy for Patients with Diabetes (SPD)

Received Statin Therapy

60.85%

67.07%

63.70%

67.01%

Statin Therapy for Patients with Diabetes (SPD)

Statin Adherence 80%

55.03%

70.37%

60.26%

70.91%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

66.67%

63.89%

55.38%

64.10%

Use of Imaging Studies for Low Back Pain (LBP)

76.00%

75.44%

63.44%

72.74%

Use of Opioids at High Dosage (HDO)

1.55%

≤ 2.19%

2.24%

≤ 2.14%

Use of Opioids from Multiple Providers (UOP)

Multiple Prescribers and Multiple Pharmacies

1.60%

≤ 0.87%

1.93%

≤ 1.22%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

59.37%

83.21%

79.32%

86.20%


NA = Not Available Due to Small Denominator
NB = No Benefit
NR = Not Reported
NQ = Not Required
BR = Biased Rate